Key result
A newly developed qPCR assay for detecting vesicular stomatitis virus G glycoprotein (VSV-G) sequences demonstrated sensitivity, linearity, specificity, and reproducibility with a low false-positive rate.
A newly developed qPCR assay provides a rapid alternative to 6-week cell-based assays for detecting replication-competent lentivirus in cell therapy products intended for fresh infusion.
RCL testing protocols warrant continued vigilance in lentiviral cell therapies; Level 3 data leaves optimal assay standardization open.
Lentiviral vectors are a common tool used to introduce new and corrected genes into cell therapy products for treatment of human diseases. Although lentiviral vectors are ideal for delivery and stable integration of genes of interest into the host cell genome, they potentially pose risks to human health, such as integration-mediated transformation and generation of a replication competent lentivirus (RCL) capable of infecting non-target cells. In consideration of the latter risk, all cell-based products modified by lentiviral vectors and intended for patient use must be tested for RCL prior to treatment of the patient. Current Food and Drug Administration (FDA) guidelines recommend use of cell-based assays to this end, which can take up to 6 weeks for results. However, qPCR-based assays are a quick alternative for rapid assessment of RCL in products intended for fresh infusion. We describe here the development and qualification of a qPCR assay based on detection of envelope gene sequences (vesicular stomatitis virus G glycoprotein [ VSV-G ]) for RCL in accordance with Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines. Our results demonstrate the sensitivity, linearity, specificity, and reproducibility of detection of VSV-G sequences, with a low false-positive rate. These procedures are currently being used in our phase 1 clinical investigations.
No takes yet. Share an insight, caveat, or question.
Skrdlant et al. (2017) studied Cell therapy products modified by lentiviral vectors. qPCR assay for VSV-G vs. Cell-based assays was evaluated on Sensitivity, linearity, specificity, and reproducibility of detection of VSV-G sequences. A newly developed qPCR assay for detecting vesicular stomatitis virus G glycoprotein (VSV-G) sequences demonstrated sensitivity, linearity, specificity, and reproducibility with a low false-positive rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: